Chronic kidney disease of unknown etiology (CKDu) is a progressive condition with unclear pathogenic mechanisms and limited non-invasive biomarkers. Urinary peptidomics provides a powerful tool for identifying disease-related molecular alterations and discovering potential diagnostic biomarkers.